Should hypogonadal men who are suboptimally responsive to testosterone gel switch to another gel preparation?

Abstract

DESIGN AND INTERVENTION This retrospective, uncontrolled study identified hypogonadal men who received testosterone gel between 2003 and 2006, and who had changed gel brands. At the time of the study, AndroGel® (Solvay Pharmaceuticals, Brussels, Belgium) and Testim® (Auxilium Pharmaceuticals, Malvern, PA, USA) were the only FDA-approved gels for… (More)
DOI: 10.1038/ncpuro1057

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.